Thyrocare Technologies Quarterly Results for Trading Insights
In Mar 2026, Thyrocare Technologies (THYROCARE) reported revenue ₹229 Cr and net profit ₹49 Cr — revenue +19.3% YoY. For annual financials, live price and key ratios, visit Thyrocare Technologies share price screener.
THYROCARE Quarterly Results — Revenue, Profit & EPS Highlights
Thyrocare Technologies latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore THYROCARE price trends to track price trends across different timeframes.
- Revenue of ₹229 Cr in Mar 2026 (+4.1% vs Sept 2025, +19.3% vs Mar 2025)
- Net Profit of ₹49 Cr in Mar 2026 (+2.1% vs Sept 2025, +122.7% vs Mar 2025)
- EBITDA of ₹80 Cr in Mar 2026 (+6.7% vs Sept 2025)
- Operating Margin of 34.0% in Mar 2026 (+1.0pp vs Sept 2025)
- Earnings Per Share of ₹2.99 in Mar 2026 (-67.0% vs Sept 2025)
Thyrocare Technologies Quarterly Results — Revenue, EBITDA, Net Profit & EPS
THYROCARE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 229 | 220 | 192 | 198 | 201 | 4.1% | 19.3% |
| Net Profit (₹ Cr) | 49 | 48 | 22 | 38 | 28 | - | - |
| EBITDA (₹ Cr) | 80 | 75 | 62 | 63 | 57 | - | - |
| EPS (₹) | 2.99 | 9.05 | 4.17 | 7.35 | 1.82 | - | - |
| Operating Margin (%) | 34.0% | 33.0% | 30.0% | 30.0% | 26.0% | - | - |
THYROCARE Share Price Trend — 1-Year Movement Across Quarterly Results
Thyrocare Technologies 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with THYROCARE stock valuation models to assess whether the stock is under or overvalued.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
THYROCARE vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Thyrocare Technologies latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Mar 2026 |
₹118,945.86 Cr | 8272.5 | 6,660 | 551 | +4.6% | +17.6% | 8.3% | 224.7 |
|
Max Healthcare Inst…
Sept 2025 |
₹96,724.76 Cr | 993.5 | 2,168 | 491 | +10.8% | - | 22.6% | 196.7 |
|
Fortis Healthcare
Mar 2026 |
₹73,257.36 Cr | 960.9 | 2,375 | 271 | -0.3% | +16.9% | 11.4% | 273.0 |
|
Aster DM Healthcare
Mar 2026 |
₹39,252.85 Cr | 741.3 | 1,219 | 154 | -0.6% | +18.1% | 12.6% | 272.5 |
|
Narayana Hrudayalaya
Mar 2026 |
₹38,951.17 Cr | 1920.2 | 2,623 | 224 | +57.3% | +74.5% | 8.5% | 174.2 |
All amounts in ₹ Crores